A study to test if a third dose of the vaccine is safe in current and former smokers aged 40 to 80 years old and to gather information on the immune response following the third dose of the vaccine

Trial Identifier: 207759
Sponsor: GlaxoSmithKline
Start Date: March 2018
Primary Completion Date: December 2019
Study Completion Date: September 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Canada, Nova Scotia Truro, Nova Scotia, Canada, B2N 1L2
Canada, Québec Sherbrooke, Québec, Canada, J1J 2G2
Germany, Bayern Wuerzburg, Bayern, Germany, 97070
Germany, Nordrhein-Westfalen Goch, Nordrhein-Westfalen, Germany, 47574
United Kingdom Axbridge, Somerset, United Kingdom, BS26 2BJ
United Kingdom, Derbyshire Chesterfield, Derbyshire, United Kingdom, S40 4AA
United Kingdom, Northamptonshire Wellingborough, Northamptonshire, United Kingdom, NN8 4RW
United Kingdom, Wiltshire Chippenham, Wiltshire, United Kingdom, SN15 2SB